|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.359
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.319
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.294
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.293
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.241
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.226
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.219
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.192
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.191
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.180
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.172
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.169
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.159
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.155
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.150
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.148
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.141
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.140
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.139
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.124
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.121
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.118
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.117
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.114
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.110
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.109
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.109
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.102
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.101
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.101
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.098
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.094
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.094
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.093
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.093
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.092
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.090
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.088
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.086
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.086
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.084
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.084
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.083
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.083
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.083
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.079
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.079
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.078
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.077
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.074
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.074
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.073
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.072
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.072
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.070
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.069
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.068
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.067
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.067
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.067
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.067
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.067
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.066
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
23 |
0.066
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.066
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.065
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.064
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.063
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.063
|
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.062
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.062
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.062
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.061
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.060
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.060
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.060
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.059
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.059
|
|
|
|
regulation of cardiac chamber morphogenesis
|
GO:1901219 |
2 |
0.059
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.059
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.059
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.059
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.058
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.058
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.058
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.058
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.058
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.057
|
|
|
|
endocardial cushion formation
|
GO:0003272 |
13 |
0.057
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.056
|
|
|
|
memory
|
GO:0007613 |
58 |
0.056
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.054
|
|
|
|
vagus nerve morphogenesis
|
GO:0021644 |
2 |
0.054
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.054
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.053
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.053
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.053
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.053
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.052
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.051
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.051
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.051
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.051
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.050
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.049
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.049
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.049
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.049
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.048
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.048
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.048
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.048
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.048
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.048
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.048
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.047
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.047
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.046
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.046
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.046
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.045
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.045
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.045
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.045
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.045
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.045
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.044
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.044
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.044
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.044
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.044
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.044
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.043
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.043
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.043
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.043
|
|
|
|
alpha beta t cell differentiation involved in immune response
|
GO:0002293 |
30 |
0.043
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.043
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.042
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.042
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.042
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.042
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.042
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.041
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.041
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.041
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.041
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.041
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.040
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.040
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.040
|
|
|
|
sinoatrial node cell differentiation
|
GO:0060921 |
3 |
0.040
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.040
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.039
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.039
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.039
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.039
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.039
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.039
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.039
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.038
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.038
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.038
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.038
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.038
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.038
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.038
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.037
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.037
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.037
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.037
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.037
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.037
|
|
|
|
positive regulation of b cell activation
|
GO:0050871 |
49 |
0.037
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.037
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.037
|
|
|
|
t cell differentiation involved in immune response
|
GO:0002292 |
30 |
0.037
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.037
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.037
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.037
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.037
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.037
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.037
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.036
|
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.036
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.036
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.036
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.036
|
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.036
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.036
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.036
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.036
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.035
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.035
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.035
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.035
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.035
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.035
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.035
|
|
|
|
cell migration involved in endocardial cushion formation
|
GO:0003273 |
3 |
0.035
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.035
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.034
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.034
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.034
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.034
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.034
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.034
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.034
|
|
|
|
learning
|
GO:0007612 |
98 |
0.034
|
|
|
|
ventricular trabecula myocardium morphogenesis
|
GO:0003222 |
11 |
0.033
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.033
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.033
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.033
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.033
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.033
|
|
|
|
mesodermal to mesenchymal transition involved in gastrulation
|
GO:0060809 |
1 |
0.033
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.033
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.033
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.033
|
|
|
|
sinoatrial node cell development
|
GO:0060931 |
3 |
0.033
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.033
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.033
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.033
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.032
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.032
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.032
|
|
|
|
sinoatrial node development
|
GO:0003163 |
4 |
0.032
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.032
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.032
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.032
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.032
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.032
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.032
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.032
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.032
|
|
|
|
positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010579 |
3 |
0.032
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.032
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.031
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.031
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.031
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.031
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.031
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.031
|
|
|
|
detection of chemical stimulus involved in sensory perception of smell
|
GO:0050911 |
4 |
0.031
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.031
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.031
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.031
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.031
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.031
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.031
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.030
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.030
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.030
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.030
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.030
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.030
|
|
|
|
cochlea development
|
GO:0090102 |
35 |
0.030
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.030
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.030
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.030
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.030
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.030
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.030
|
|
|
|
olfactory bulb development
|
GO:0021772 |
30 |
0.030
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.030
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.030
|
|
|
|
positive regulation of heart growth
|
GO:0060421 |
18 |
0.030
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.030
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.030
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.030
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.029
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.029
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.029
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.029
|
|
|
|
heart formation
|
GO:0060914 |
16 |
0.029
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.029
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.029
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.029
|
|
|
|
mesenchyme morphogenesis
|
GO:0072132 |
32 |
0.029
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.029
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.029
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.029
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.029
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.028
|
|
|
|
regulation of organ formation
|
GO:0003156 |
34 |
0.028
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.028
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.028
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.028
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.028
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.028
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.028
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.028
|
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.028
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.028
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.028
|
|
|
|
foregut regionalization
|
GO:0060423 |
3 |
0.028
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.028
|
|
|
|
nephron tubule formation
|
GO:0072079 |
20 |
0.028
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.028
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.028
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.028
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.027
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.027
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.027
|
|
|
|
positive regulation of white fat cell proliferation
|
GO:0070352 |
1 |
0.027
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.027
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.027
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.027
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.027
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.027
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.027
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.027
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.027
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.027
|
|
|
|
regulation of microtubule based process
|
GO:0032886 |
52 |
0.027
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.027
|
|
|
|
axis elongation
|
GO:0003401 |
30 |
0.027
|
|
|
|
hypothalamic tangential migration using cell axon interactions
|
GO:0021856 |
3 |
0.027
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.027
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.027
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.027
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.026
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.026
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.026
|
|
|
|
regulation of skeletal muscle fiber differentiation
|
GO:1902809 |
3 |
0.026
|
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.026
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.026
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.026
|
|
|
|
mesenchymal epithelial cell signaling involved in lung development
|
GO:0060496 |
1 |
0.026
|
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.026
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.026
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.026
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.026
|
|
|
|
establishment or maintenance of polarity of embryonic epithelium
|
GO:0016332 |
1 |
0.026
|
|
|
|
somatic recombination of immunoglobulin gene segments
|
GO:0016447 |
42 |
0.026
|
|
|
|
somatic diversification of immune receptors
|
GO:0002200 |
53 |
0.026
|
|
|
|
positive regulation of mesenchymal cell proliferation involved in ureter development
|
GO:2000729 |
3 |
0.025
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.025
|
|
|
|
foregut morphogenesis
|
GO:0007440 |
12 |
0.025
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.025
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.025
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.025
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.025
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.025
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.025
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.025
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.025
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.025
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.025
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901228 |
4 |
0.025
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.025
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.025
|
|
|
|
left right pattern formation
|
GO:0060972 |
23 |
0.025
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.025
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.024
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.024
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.024
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.024
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.024
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.024
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.024
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.024
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.024
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.024
|
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.024
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.024
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.024
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.024
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.024
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.024
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.024
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.024
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.023
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.023
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.023
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.023
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.023
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.023
|
|
|
|
morphogenesis of an epithelial sheet
|
GO:0002011 |
27 |
0.023
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.023
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.023
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.023
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.023
|
|
|
|
somatic recombination of immunoglobulin genes involved in immune response
|
GO:0002204 |
36 |
0.023
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.023
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.023
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.023
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.023
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.023
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.023
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.023
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.023
|
|
|
|
somatic diversification of immunoglobulins involved in immune response
|
GO:0002208 |
36 |
0.022
|
|
|
|
regulation of mesenchymal cell proliferation involved in ureter development
|
GO:0072199 |
3 |
0.022
|
|
|
|
specification of loop of henle identity
|
GO:0072086 |
4 |
0.022
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.022
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.022
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.022
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.022
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.022
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.022
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.022
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.022
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.022
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.022
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.022
|
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.022
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.022
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.022
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.022
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.022
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.022
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.022
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.022
|
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
69 |
0.022
|
|
|
|
tendon sheath development
|
GO:0002932 |
1 |
0.021
|
|
|
|
negative regulation of cardiac chamber formation
|
GO:1901211 |
1 |
0.021
|
|
|
|
negative regulation of axon extension
|
GO:0030517 |
19 |
0.021
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.021
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.021
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.021
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.021
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.021
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.021
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.021
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.021
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.021
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.021
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.021
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.021
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.021
|
|
|
|
visceral motor neuron differentiation
|
GO:0021524 |
3 |
0.021
|
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.021
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.021
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.021
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.021
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.021
|
|
|
|
blood vessel remodeling
|
GO:0001974 |
33 |
0.021
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.021
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.020
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.020
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.020
|
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.020
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.020
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.020
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.020
|
|
|
|
regulation of white fat cell proliferation
|
GO:0070350 |
2 |
0.020
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.020
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.020
|
|
|
|
positive regulation of mesoderm development
|
GO:2000382 |
2 |
0.020
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.020
|
|
|
|
tongue development
|
GO:0043586 |
18 |
0.020
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.020
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.020
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.020
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.020
|
|
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
38 |
0.020
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.020
|
|
|
|
negative regulation of muscle cell differentiation
|
GO:0051148 |
33 |
0.020
|
|
|
|
cardiac muscle cell proliferation
|
GO:0060038 |
31 |
0.020
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.020
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.020
|
|
|
|
corticosterone secretion
|
GO:0035934 |
3 |
0.019
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.019
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.019
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.019
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.019
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.019
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.019
|
|
|
|
semicircular canal fusion
|
GO:0060879 |
1 |
0.019
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.019
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.019
|
|
|
|
mating behavior sex discrimination
|
GO:0048047 |
1 |
0.019
|
|
|
|
vascular endothelial growth factor receptor signaling pathway
|
GO:0048010 |
24 |
0.019
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.019
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.019
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.019
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.019
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.019
|
|
|
|
regulation of dna recombination
|
GO:0000018 |
34 |
0.019
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.019
|
|
|
|
embryonic hindlimb morphogenesis
|
GO:0035116 |
32 |
0.019
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.019
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.019
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.019
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.019
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.019
|
|
|
|
regulation of cardiac chamber formation
|
GO:1901210 |
1 |
0.019
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.019
|
|
|
|
general adaptation syndrome
|
GO:0051866 |
2 |
0.019
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.019
|
|
